text: BAFF-R-targeted CAR R/R NHL @elizabeth_budde #ASH24:
  - 6 pts: 4 MCL, 1 THRBCL, 1 MZL, half prior CD19 CAR
  - no DLTs: all G1 CRS, 2 G1 ICANS
  - of 5 evaluable pts, all had CRs! (ongoing responses 4-20 mos)
  Need CAR products like this for post-CD20 & CD19-targeted therapies. #lymsm